Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant APC

Human Immunology

Volumn 61, Issue 2, 2000, Pages 120-130

  Purcell, Anthony W ^a   Kelly, Alexandra J ^b   Peh, Chen Au ^b   Dudek, Nadine L ^b   McCluskey, James ^b  

^a Univ M   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

721.220; Antigen presentation; HLA B27; T2; Tapasin

Indexed keywords

EPITOPE; HLA B27 ANTIGEN; TAPASIN;

ALLELE; ANTIGEN EXPRESSION; CELL CULTURE; CONFERENCE PAPER; CONFORMATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STABILITY;

ANTIGEN-PRESENTING CELLS; ANTIPORTERS; BREFELDIN A; CELLS, CULTURED; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULINS; MEMBRANE TRANSPORT PROTEINS; MUTATION;

EID: 0033972943     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00139-1     Document Type: Conference Paper

References (33)

1. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 16:1998;323.
2. Hughes E.A., Cresswell P. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr Biol. 8:1998;709.
3. Lindquist J.A., Jensen O.N., Mann M., Hammerling G.J. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 17:1998;2186.
4. Salter R.D., Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5:1986;943.
5. Young N.T., Mulder A., Cerundolo V., Claas F.H., Welsh K.I. Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens. 52:1998;368.
6. Henderson R.A., Michel H., Sakaguchi K., Shabaniwitz J., Appela E., Hunt D.F., Engelhard V.H. HLA-A2.1-associated peptides from a mutant cell line a second pathway of antigen presentation . Science. 255:(5049):1992;1264.
7. Wei M.L., Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 356:1992;443.
8. Anderson K.S., Alexander J., Wei M., Cresswell P. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J Immunol. 151:1993;3407.
9. Colbert R.A., Rowland-Jones S.L., McMichael A.J., Frelinger J.A. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. Proc Natl Acad Sci USA. 90:1993;6879.
10. Dong T., Boyd D., Rosenberg W., Alp N., Takiguchi M., McMichael A., Rowland-Jones S. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur J Immunol. 26:1996;335.
11. Tan L., Andersen M.H., Elliott T., Haurum J.S. An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC molecules. J Immunol Methods. 209:1997;25.
12. Greenwood R.S., Shimizu Y., Sekhon G.S., DeMars R. Novel allele specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J Immunol. 153:1994;5525.
13. Copeman J., Bangia N., Cross J.C., Cresswell P. Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alternative splicing of the tapasin gene. Eur J Immunol. 28:1998;3783.
14. Grandea A.G. 3rd, Lehner P.J., Cresswell P., Spies T. Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics. 46:1997;477.
15. Grandea A.G.A. 3rd, Androlewicz M.J., Athwal R.S., Gerarghty D.E., Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science. 270:1995;105.
16. Peh C.A., Burrows S.R., Barnden M., Khanna R., Cresswell P., Moss D.J., McCluskey J. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity. 8:1998;531.
17. Lewis J.W., Sewell A., Price D., Elliott T. HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin. Eur J Immunol. 28:1998;3214.
18. Lehner P.J., Surman M.J., Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line 220 . Immunity. 8:1998;221.
19. Salter R.D., Howell D.N., Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:1985;235.
20. Forero L., Zwirner N.W., Fink C.W., Fernandez-Vina M.A., Stastny P. Juvenile arthritis, HLA-A2 and binding of DEK oncogene-peptides. Hum Immunol. 59:1998;443.
21. Parham P.B., Barnstable C.J., Bodmer W.F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol. 123:1979;342.
22. Grumet F.C., Fendly B.M., Engleman E.G. Monoclonal anti-HLA-B27 antibody (B27M1) production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls . Lancet. 2:1981;174.
23. Grumet F.C., Fendly B.M., Fish L., Foung S., Engleman E.G. Monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol. 5:1982;61.
24. Huang F., Hermann E., Wang J., Cheng X.-K., Tsai W.C., Wen J., Kuipers J.G., Kellner H., Ackermann B., Roth G., Williams K.M., Yu D.T.Y., Raybourne R.B. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences. Infect Immun. 64:1996;120.
25. Wang J., Yu D.T., Fukazawa T., Kellner H., Wen J., Cheng X.K., Roth G., Williams K.M., Raybourne R.B. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol. 152:1994;1197.
26. Urban R.G., Chicz R.M., Lane W.S., Strominger J.L., Rehm A., Kenter M.J., UytdeHaag F.G., Ploegh H., Uchanska-Ziegler B., Ziegler A. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci USA. 91:1994;1534.
27. Stam N.J.S., Spits H., Pleogh H. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterisation of certain HLA-C locus products. J Immunol. 137:1986;2299.
28. Carreno B.M., Hansen T.H. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface. Eur J Immunol. 24:1994;1285.
29. Stam N.J., Vroom T.M., Peters P.J., Pastoors E.B., Ploegh H.L. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol. 2:(2):1990;113.
30. Benjamin R.J.M., Madrigal J.A., Parham P. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature. 351:1991;74.
31. Colbert R.A., Rowland-Jones S.L., McMichael A.J., Frelinger J.A. Differences in peptide presentation between B27 subtypes the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703 . Immunity. 1:1994;121.
32. Nuchtern J.G., Bonifacino J.S., Biddison W.E., Klausner R.D. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature. 339:1989;223.
33. Ellis S.A., Taylor C., McMichael A. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol. 5:1982;49.